These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
144 related articles for article (PubMed ID: 15883918)
1. American Chemical Society - 229th National Meeting: bench to pilot plant. Rotella DP IDrugs; 2005 May; 8(5):390-1. PubMed ID: 15883918 [No Abstract] [Full Text] [Related]
2. [Phosphosdiesterase 4 inhibitors in the treatment of pulmonary diseases]. Xia XD; Dai YR; Xu ZJ Zhonghua Jie He He Hu Xi Za Zhi; 2004 Jan; 27(1):57-9. PubMed ID: 14989829 [No Abstract] [Full Text] [Related]
6. COPD, inflammation and its modulation by phosphodiesterase 4 inhibitors: time to look beyond the FEV1. Celli B Chest; 2006 Jan; 129(1):5-6. PubMed ID: 16424403 [No Abstract] [Full Text] [Related]
7. Phosphodiesterase 4 inhibitors: antiinflammatory therapy for chronic obstructive pulmonary disease at last? Kerstjens HA; Timens W Am J Respir Crit Care Med; 2003 Oct; 168(8):914-5. PubMed ID: 14555456 [No Abstract] [Full Text] [Related]
8. [Inflammatory lung and systemic disease]. Med Monatsschr Pharm; 2005 Jul; 28(7):254-5. PubMed ID: 16038131 [No Abstract] [Full Text] [Related]
9. The potential role of roflumilast: the new phosphodiesterase-4 inhibitor. Karish SB; Gagnon JM Ann Pharmacother; 2006 Jun; 40(6):1096-104. PubMed ID: 16735669 [TBL] [Abstract][Full Text] [Related]
10. Selective phosphodiesterase 4 inhibitors in the treatment of allergy and inflammation. Smith VB; Spina D Curr Opin Investig Drugs; 2005 Nov; 6(11):1136-41. PubMed ID: 16312135 [TBL] [Abstract][Full Text] [Related]
11. Phosphodiesterase inhibitors in airways disease. Fan Chung K Eur J Pharmacol; 2006 Mar; 533(1-3):110-7. PubMed ID: 16458289 [TBL] [Abstract][Full Text] [Related]
12. Phosphodiesterase-4: selective and dual-specificity inhibitors for the therapy of chronic obstructive pulmonary disease. Giembycz MA Proc Am Thorac Soc; 2005; 2(4):326-33; discussion 340-1. PubMed ID: 16267357 [TBL] [Abstract][Full Text] [Related]
13. Selective phosphodiesterase inhibitors for the treatment of asthma and chronic obstructive pulmonary disease. Grootendorst DC; Rabe KF Curr Opin Allergy Clin Immunol; 2002 Feb; 2(1):61-7. PubMed ID: 11964752 [TBL] [Abstract][Full Text] [Related]
14. Synthesis, biological evaluation and molecular modelling studies on benzothiadiazine derivatives as PDE4 selective inhibitors. Tait A; Luppi A; Hatzelmann A; Fossa P; Mosti L Bioorg Med Chem; 2005 Feb; 13(4):1393-402. PubMed ID: 15670947 [TBL] [Abstract][Full Text] [Related]
15. PDE4D-deficient mice knock the breath out of asthma. Giembycz M Trends Pharmacol Sci; 2000 Aug; 21(8):291-2. PubMed ID: 10918631 [No Abstract] [Full Text] [Related]
16. Phosphodiesterase-4 inhibitors in the treatment of inflammatory lung disease. Spina D Drugs; 2003; 63(23):2575-94. PubMed ID: 14636078 [TBL] [Abstract][Full Text] [Related]
17. The potential of PDE4 inhibitors in asthma or COPD. Spina D Curr Opin Investig Drugs; 2000 Oct; 1(2):204-13. PubMed ID: 11249575 [TBL] [Abstract][Full Text] [Related]
18. Chronic Obstructive Pulmonary Disease--SMi's Second Annual Conference. 10-11 March 2004, London, UK. De La Rue SA IDrugs; 2004 Apr; 7(4):318-22. PubMed ID: 15057634 [TBL] [Abstract][Full Text] [Related]
19. American Chemical Society--229th National Meeting. Kinase modulators. Mackonochie M; Chan D IDrugs; 2005 Apr; 8(4):283-4. PubMed ID: 15800796 [No Abstract] [Full Text] [Related]
20. American Chemical Society--229th National Meeting. Oncology. Chan D; Mackonochie M IDrugs; 2005 Apr; 8(4):280-2. PubMed ID: 15800795 [No Abstract] [Full Text] [Related] [Next] [New Search]